DNB Asset Management AS Has $19.57 Million Stock Position in Axon Enterprise, Inc $AXON

DNB Asset Management AS increased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 24.6% during the 3rd quarter, HoldingsChannel reports. The fund owned 27,267 shares of the biotechnology company’s stock after purchasing an additional 5,379 shares during the quarter. DNB Asset Management AS’s holdings in Axon Enterprise were worth $19,568,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in Axon Enterprise by 4.2% in the third quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock worth $6,684,217,000 after purchasing an additional 376,904 shares during the period. Geode Capital Management LLC boosted its stake in shares of Axon Enterprise by 5.9% in the 2nd quarter. Geode Capital Management LLC now owns 2,072,186 shares of the biotechnology company’s stock valued at $1,713,332,000 after purchasing an additional 115,349 shares during the last quarter. Jennison Associates LLC grew its position in shares of Axon Enterprise by 53.8% during the 3rd quarter. Jennison Associates LLC now owns 943,944 shares of the biotechnology company’s stock worth $677,412,000 after buying an additional 330,213 shares during the period. Vestor Capital LLC grew its position in shares of Axon Enterprise by 438,636.3% during the 2nd quarter. Vestor Capital LLC now owns 833,599 shares of the biotechnology company’s stock worth $690,170,000 after buying an additional 833,409 shares during the period. Finally, Norges Bank bought a new stake in shares of Axon Enterprise during the second quarter worth approximately $637,806,000. Institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. William Blair reaffirmed an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 3rd. Northcoast Research raised Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 price target on the stock in a research note on Tuesday, January 6th. Wall Street Zen upgraded Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday. Robert W. Baird set a $800.00 price objective on Axon Enterprise in a research note on Wednesday. Finally, Needham & Company LLC dropped their price objective on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating for the company in a report on Friday, February 20th. Sixteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $762.93.

Insider Buying and Selling at Axon Enterprise

In related news, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $552.60, for a total value of $11,052,000.00. Following the completion of the transaction, the president owned 249,502 shares of the company’s stock, valued at approximately $137,874,805.20. This trade represents a 7.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jeffrey C. Kunins sold 1,797 shares of the business’s stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $539.23, for a total transaction of $968,996.31. Following the sale, the insider directly owned 83,485 shares in the company, valued at $45,017,616.55. This trade represents a 2.11% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 58,040 shares of company stock valued at $32,251,738 in the last three months. 4.40% of the stock is currently owned by insiders.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q4 beat and bullish bookings — Axon reported a double beat (EPS and revenue), ~39% revenue growth and a material increase in future contracted bookings with raised multi‑year sales targets, which triggered the stock rally. Read More.
• Positive Sentiment: AI narrative driving subscription demand — Coverage highlights that Axon’s AI features (body‑camera analytics, Draft One report drafting, evidence management) are accelerating software adoption and upsells, supporting revenue visibility beyond hardware. Read More.
• Neutral Sentiment: Analysts recalibrating models — Several firms trimmed price targets after the print (Piper Sandler, others); many maintained buy/overweight stances, so these moves reflect model updates and volatility rather than a wholesale negative verdict. Read More.
• Neutral Sentiment: Short‑interest data flagged as anomalous — Recent short‑interest reports show zero/NaN figures (likely a reporting anomaly); nothing actionable from that data point for now.
• Negative Sentiment: Some analysts flag downside risk — Morgan Stanley and UBS issued more cautious outlooks/pessimistic scenarios that could cap upside if execution or margins slip. Read More. | Read More.
• Negative Sentiment: Profitability and margin recovery remain a watch item — Commentators note fast revenue growth but slower profit improvement and the need for FCF conversion; sustained margin progress is required to justify high multiples. Read More.
• Negative Sentiment: Insider sale disclosed — CEO Patrick Smith sold 10,000 shares (~$5.0M) on Feb. 25; small relative to his holdings but notable to traders monitoring insider activity. Read More.

Axon Enterprise Trading Down 1.4%

Shares of NASDAQ AXON opened at $542.40 on Friday. Axon Enterprise, Inc has a twelve month low of $396.41 and a twelve month high of $885.91. The stock has a market cap of $43.61 billion, a price-to-earnings ratio of 356.84, a P/E/G ratio of 16.57 and a beta of 1.48. The company has a quick ratio of 2.89, a current ratio of 2.53 and a debt-to-equity ratio of 0.53. The company’s fifty day moving average is $537.92 and its 200-day moving average is $625.54.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, topping the consensus estimate of $1.60 by $0.55. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The business had revenue of $796.72 million for the quarter, compared to the consensus estimate of $755.29 million. During the same quarter last year, the business posted $2.08 EPS. The firm’s revenue was up 38.5% compared to the same quarter last year. Equities research analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.